These often short term, usually intensive programs help early-stage businesses grow quickly and become investment ready. The programs can offer guidance in pitching, funding, product development and marketing via selective mentorship with industry experts, investors and entrepreneurs. Some of the established, niche accelerators can provide early insights into the next wave of biotechnology companies.

Charlie Munger summed it up best, ‘knowing what you don’t know is more useful than being brilliant’. Investing without seeking input from others creates many challenges. The main one being the difficulty in avoiding confirmation bias. Without others to challenge us, we are innately wired to view our current investments through ‘rose colored’ glasses. It

There are a number of useful websites available to biotechnology and life sciences investors in Australia. They include:

There are a number of free publications available to biotechnology and life sciences investors in Australia. They include:

In Australia there a few main players that provide venture capital funding to our progressive biotechnology ventures. Most of these venture capital firms are available conduits for sophisticated investors to access later stage, more proven life sciences companies. Examining the portfolios of these VC firms can provide investors with insights into business that may IPO

Conference and events can provide some of the richest learning opportunities for people in this field. Being able to speak to industry participants and experts can result in unique insights. Additionally, opportunities to discuss ideas with fellow investors is also invaluable. Below is a select list of events that may interest investors. Dates and conference

Podcasts are one of the new mediums for information sharing. The ability to learn this way is attractive to many. Over the last few years podcasts promoting and educating listeners in opportunities and advances in Australian biotechnology are becoming more abundant. Some of the more popular podcasts available in this field are as follows:

Australian investors have long had a passion for investment in the healthcare sector. The darling company that first comes to mind in this category is none other than CSL. Created in 1916 as the government body, Commonwealth Serum Laboratories, it listed on the ASX in 1994 at a market capitalization of $299 million. It has